Enitan Odeyemi, Director, Business Development, Codix Pharma Ltd; Mary Ogangwu - Chief Operating Officer, Codix Pharma Ltd; Kingsley Aguoru - Chief Operating Officer, Colexa Biosensor Ltd; Olanrewaju ...

There may have been no big billion-dollar rounds this week, but there were lots of good-sized financings for a variety of ...

Researchers use biocompatible polydopamine nanoparticles and near-infrared light to remotely trigger activity in neuron and ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

This study highlights the successful development of a non-invasive biosensor for glucose monitoring, addressing many ...

Philip Tinnefeld from LMU is coordinating a new doctoral training network at the interface of physics, chemistry, biology, and engineering.

LifeSignals introduces UbiqVue Holter System in partnership with UltraLinQ at Heart Rhythm 2025: Milpitas, California Wednesday, April 23, 2025, 12:00 Hrs [IST] LifeSignals, Inc., ...

The Biophotonics Market, long associated with healthcare diagnostics and advanced imaging, is undergoing a transformative ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation, granting EditCo access to Promega HiBiT, HaloTag®, and NanoLuc® technologies. These advanced protein-tagging ...

The Series C funding supports Biolinq’s transition from development stage to commercial readiness following US pivotal trial ...